BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 26018753)

  • 1. RacGAP1 Is a Novel Downstream Effector of E2F7-Dependent Resistance to Doxorubicin and Is Prognostic for Overall Survival in Squamous Cell Carcinoma.
    Hazar-Rethinam M; de Long LM; Gannon OM; Boros S; Vargas AC; Dzienis M; Mukhopadhyay P; Saenz-Ponce N; Dantzic DD; Simpson F; Saunders NA
    Mol Cancer Ther; 2015 Aug; 14(8):1939-50. PubMed ID: 26018753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel E2F/sphingosine kinase 1 axis regulates anthracycline response in squamous cell carcinoma.
    Hazar-Rethinam M; de Long LM; Gannon OM; Topkas E; Boros S; Vargas AC; Dzienis M; Mukhopadhyay P; Simpson F; Endo-Munoz L; Saunders NA
    Clin Cancer Res; 2015 Jan; 21(2):417-27. PubMed ID: 25411162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of Rac GTPase Activating Protein 1 Contributes to Proliferation of Cancer Cells by Reducing Hippo Signaling to Promote Cytokinesis.
    Yang XM; Cao XY; He P; Li J; Feng MX; Zhang YL; Zhang XL; Wang YH; Yang Q; Zhu L; Nie HZ; Jiang SH; Tian GA; Zhang XX; Liu Q; Ji J; Zhu X; Xia Q; Zhang ZG
    Gastroenterology; 2018 Oct; 155(4):1233-1249.e22. PubMed ID: 30009820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the XPO1-dependent nuclear export of E2F7 reverses anthracycline resistance in head and neck squamous cell carcinomas.
    Saenz-Ponce N; Pillay R; de Long LM; Kashyap T; Argueta C; Landesman Y; Hazar-Rethinam M; Boros S; Panizza B; Jacquemyn M; Daelemans D; Gannon OM; Saunders NA
    Sci Transl Med; 2018 Jun; 10(447):. PubMed ID: 29950445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A miR-26a/E2F7 feedback loop contributes to tamoxifen resistance in ER-positive breast cancer.
    Liu J; Li X; Wang M; Xiao G; Yang G; Wang H; Li Y; Sun X; Qin S; Du N; Ren H; Pang Y
    Int J Oncol; 2018 Oct; 53(4):1601-1612. PubMed ID: 30066905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. microRNA-935 is reduced in non-small cell lung cancer tissue, is linked to poor outcome, and acts on signal transduction mediator E2F7 and the AKT pathway.
    Wang C; Li S; Xu J; Niu W; Li S
    Br J Biomed Sci; 2019 Jan; 76(1):17-23. PubMed ID: 30203720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of Rac GTPase-activating protein 1 is significantly associated with the early recurrence of human hepatocellular carcinoma.
    Wang SM; Ooi LL; Hui KM
    Clin Cancer Res; 2011 Sep; 17(18):6040-51. PubMed ID: 21825042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-302a/d inhibits the self-renewal capability and cell cycle entry of liver cancer stem cells by targeting the E2F7/AKT axis.
    Ma YS; Lv ZW; Yu F; Chang ZY; Cong XL; Zhong XM; Lu GX; Zhu J; Fu D
    J Exp Clin Cancer Res; 2018 Oct; 37(1):252. PubMed ID: 30326936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcription factor E2F7 activates PKMYT1 to partially suppress adriamycin sensitivity in gastric cancer through the MAPK signaling pathway.
    Yang X; Zeng J; Jiang C; Zhang Y; Zhang X
    Rev Invest Clin; 2024 Mar; 76(1):6-17. PubMed ID: 38253021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. E2F7 overexpression leads to tamoxifen resistance in breast cancer cells by competing with E2F1 at miR-15a/16 promoter.
    Chu J; Zhu Y; Liu Y; Sun L; Lv X; Wu Y; Hu P; Su F; Gong C; Song E; Liu B; Liu Q
    Oncotarget; 2015 Oct; 6(31):31944-57. PubMed ID: 26397135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rac GTPase activating protein 1 promotes gallbladder cancer via binding DNA ligase 3 to reduce apoptosis.
    Bian R; Dang W; Song X; Liu L; Jiang C; Yang Y; Li Y; Li L; Li X; Hu Y; Bao R; Liu Y
    Int J Biol Sci; 2021; 17(9):2167-2180. PubMed ID: 34239347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Up-Regulation of RACGAP1 Promotes Progressions of Hepatocellular Carcinoma Regulated by GABPA via PI3K/AKT Pathway.
    Gu Y; Chen B; Guo D; Pan L; Luo X; Tang J; Yang W; Zhang Y; Zhang L; Huang J; Duan R; Wang Z
    Oxid Med Cell Longev; 2022; 2022():3034150. PubMed ID: 35958019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E2F7 can regulate proliferation, differentiation, and apoptotic responses in human keratinocytes: implications for cutaneous squamous cell carcinoma formation.
    Endo-Munoz L; Dahler A; Teakle N; Rickwood D; Hazar-Rethinam M; Abdul-Jabbar I; Sommerville S; Dickinson I; Kaur P; Paquet-Fifield S; Saunders N
    Cancer Res; 2009 Mar; 69(5):1800-8. PubMed ID: 19223542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rac GTPase-Activating Protein 1 (RACGAP1) as an Oncogenic Enhancer in Esophageal Carcinoma.
    Yin C; Toiyama Y; Okugawa Y; Shigemori T; Yamamoto A; Ide S; Kitajima T; Fujikawa H; Yasuda H; Okita Y; Hiro J; Yoshiyama S; Ohi M; Araki T; Yao L; Kusunoki M
    Oncology; 2019; 97(3):155-163. PubMed ID: 31216559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-4324-RACGAP1-STAT3-ESR1 feedback loop inhibits proliferation and metastasis of bladder cancer.
    Ge Q; Lu M; Ju L; Qian K; Wang G; Wu CL; Liu X; Xiao Y; Wang X
    Int J Cancer; 2019 Jun; 144(12):3043-3055. PubMed ID: 30511377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RhoC mediates epidermal growth factor-stimulated migration and invasion in head and neck squamous cell carcinoma.
    Tumur Z; Katebzadeh S; Guerra C; Bhushan L; Alkam T; Henson BS
    Neoplasia; 2015 Jan; 17(1):141-51. PubMed ID: 25622907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Over-expression of BAG-1 in head and neck squamous cell carcinomas (HNSCC) is associated with cisplatin-resistance.
    Liu S; Ren B; Gao H; Liao S; Zhai YX; Li S; Su XJ; Jin P; Stroncek D; Xu Z; Zeng Q; Li Y
    J Transl Med; 2017 Sep; 15(1):189. PubMed ID: 28877725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of resveratrol on doxorubicin resistance in breast neoplasm cells by modulating PI3K/Akt signaling pathway.
    Chen JM; Bai JY; Yang KX
    IUBMB Life; 2018 Jun; 70(6):491-500. PubMed ID: 29637742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor-I receptor signaling pathway induces resistance to the apoptotic activities of SCH66336 (lonafarnib) through Akt/mammalian target of rapamycin-mediated increases in survivin expression.
    Oh SH; Jin Q; Kim ES; Khuri FR; Lee HY
    Clin Cancer Res; 2008 Mar; 14(5):1581-9. PubMed ID: 18316583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RacGAP1 expression, increasing tumor malignant potential, as a predictive biomarker for lymph node metastasis and poor prognosis in colorectal cancer.
    Imaoka H; Toiyama Y; Saigusa S; Kawamura M; Kawamoto A; Okugawa Y; Hiro J; Tanaka K; Inoue Y; Mohri Y; Kusunoki M
    Carcinogenesis; 2015 Mar; 36(3):346-54. PubMed ID: 25568185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.